ZA200204859B - Method of decreasing fasting sugars and weight gains in diabetic patients. - Google Patents

Method of decreasing fasting sugars and weight gains in diabetic patients.

Info

Publication number
ZA200204859B
ZA200204859B ZA200204859A ZA200204859A ZA200204859B ZA 200204859 B ZA200204859 B ZA 200204859B ZA 200204859 A ZA200204859 A ZA 200204859A ZA 200204859 A ZA200204859 A ZA 200204859A ZA 200204859 B ZA200204859 B ZA 200204859B
Authority
ZA
South Africa
Prior art keywords
diabetic patients
weight gains
decreasing fasting
sugars
fasting sugars
Prior art date
Application number
ZA200204859A
Other languages
English (en)
Inventor
Landschulz William Harras
Original Assignee
Pfitzer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfitzer Products Inc filed Critical Pfitzer Products Inc
Publication of ZA200204859B publication Critical patent/ZA200204859B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA200204859A 2001-06-21 2002-06-18 Method of decreasing fasting sugars and weight gains in diabetic patients. ZA200204859B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30004901P 2001-06-21 2001-06-21

Publications (1)

Publication Number Publication Date
ZA200204859B true ZA200204859B (en) 2004-01-28

Family

ID=23157477

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204859A ZA200204859B (en) 2001-06-21 2002-06-18 Method of decreasing fasting sugars and weight gains in diabetic patients.

Country Status (15)

Country Link
US (2) US20030079747A1 (forum.php)
EP (1) EP1270012A1 (forum.php)
JP (1) JP2003012543A (forum.php)
KR (1) KR20020097033A (forum.php)
CN (1) CN1289143C (forum.php)
AU (1) AU4884102A (forum.php)
CA (1) CA2390757A1 (forum.php)
CZ (1) CZ20022151A3 (forum.php)
HK (1) HK1049617B (forum.php)
HU (1) HUP0202042A3 (forum.php)
IL (1) IL150209A0 (forum.php)
NZ (1) NZ519403A (forum.php)
PL (1) PL354641A1 (forum.php)
SK (1) SK9042002A3 (forum.php)
ZA (1) ZA200204859B (forum.php)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054606A1 (en) * 2002-12-13 2004-07-01 Pfizer Products Inc. Method of decreasing hepatic glucose output in diabetic patients
KR20060015472A (ko) * 2003-03-04 2006-02-17 더 테크놀로지 디벨로프먼트 컴퍼니 리미티드 약물전달 시스템 및 세포 치료법
JP2009519972A (ja) * 2005-12-15 2009-05-21 アキュスフィア, インコーポレイテッド 粒子ベースの経肺投与または経鼻投与用製薬の製造方法
WO2008118387A2 (en) * 2007-03-23 2008-10-02 Wayne State University Erythrocyte atp-release modulators
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
JP5650734B2 (ja) * 2009-07-22 2015-01-07 イーライ リリー アンド カンパニー 薬物療法に関連する体重増加を予測するための方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
DK10191D0 (da) * 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
DE69230613T2 (de) * 1991-07-02 2000-12-28 Inhale Inc Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform
US5320094A (en) * 1992-01-10 1994-06-14 The Johns Hopkins University Method of administering insulin
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
AU689217B2 (en) * 1994-03-07 1998-03-26 Novartis Ag Methods and compositions for pulmonary delivery of insulin
CZ289029B6 (cs) * 1994-09-21 2001-10-17 Inhale Therapeutic Systems Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
DE69920767T2 (de) * 1998-10-16 2006-02-02 Novo Nordisk A/S Stabile konzentrierte Insulin Präparationen zur pulmonaren Verabreichung
EP1173482A1 (en) * 1999-04-27 2002-01-23 Eli Lilly And Company Insulin crystals for pulmonary administration
EP1196445A1 (en) * 1999-06-29 2002-04-17 Eli Lilly And Company Insulin crystals for pulmonary administration
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
CA2443325C (en) * 2001-04-04 2011-06-14 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
CZ20033182A3 (cs) * 2001-05-21 2004-09-15 Nektar Therapeutics Inzulínový prostředek a způsob podávání inzulínu

Also Published As

Publication number Publication date
HK1049617B (zh) 2007-03-16
CZ20022151A3 (cs) 2003-04-16
EP1270012A1 (en) 2003-01-02
HUP0202042A2 (hu) 2004-05-28
CA2390757A1 (en) 2002-12-21
HU0202042D0 (forum.php) 2002-08-28
KR20020097033A (ko) 2002-12-31
JP2003012543A (ja) 2003-01-15
US20050220722A1 (en) 2005-10-06
US20030079747A1 (en) 2003-05-01
NZ519403A (en) 2005-03-24
CN1393265A (zh) 2003-01-29
PL354641A1 (en) 2002-12-30
SK9042002A3 (en) 2003-05-02
IL150209A0 (en) 2002-12-01
HK1049617A1 (en) 2003-05-23
CN1289143C (zh) 2006-12-13
HUP0202042A3 (en) 2004-06-28
AU4884102A (en) 2003-01-02

Similar Documents

Publication Publication Date Title
AU2001282550A1 (en) Method of quantifying total hemoglobin and glycohemoglobin
GB2385280B (en) Gaming system and gaming method
AU2003230813A1 (en) Online league and tournament system
AU2003248675A1 (en) Gaming system and method
IL164400A0 (en) Deruvatuves if n-Äphenyl(piperidin-2-yl)methylÜbenzamide, the preparation method thereof and application of same in therapeutics
AU2002310076A1 (en) Structure and method to preserve sti during etching
AU2003245026A1 (en) Multipurpose processor, system and method
AU2001276952A1 (en) Method of treating the syndrome of coronary heart disease risk factors in humans
AU2003214775A1 (en) Physiologically compatible cardiac assist device and method
GB0110288D0 (en) Composition and treatment method
PL354191A1 (en) Laminated material, application thereof and method of obtaining same
AU2003214725A1 (en) Preventing and/or treating cardiovascular disease and/or associated heart failure
AU2002367023A1 (en) Compositions and methods for treating heart failure
AU2002351206A1 (en) Lateral lubistor structure and method
AU2002349237A1 (en) Coring system and method
AU2002320056A1 (en) Apparatus and method for reducing heart pump backflow
AU2002365057A1 (en) Compositions and methods for treating heart failure
ZA200204859B (en) Method of decreasing fasting sugars and weight gains in diabetic patients.
AU2003224956A1 (en) Reference structures and reference structure enhanced tomography
AU2002366813A1 (en) Cardiac pacing method and system
AU2002316162A1 (en) Method of increasing anti-neugc antibody levels in blood
AU1907901A (en) Sandwich construction and method for its manufacture
AU2003278754A1 (en) Motocycle lift bar and method
AU2001275959A1 (en) Method of treating the syndrome of type 2 diabetes in humans
AU2003228787A1 (en) Composition and method for reducing post-prandial blood glucose